Pfizer gets a public dressing down over promoting unlicensed drugsBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7340.753/a (Published 30 March 2002) Cite this as: BMJ 2002;324:753
- Paul Dinsdale
The pharmaceutical company Pfizer has been given a rare public reprimand by the Association of the British Pharmaceutical Industry after being found in breach of the industry's code of conduct.
The Prescription Medicines Code of Practice Authority, which monitors complaints about drug companies, found that Pfizer had been using a team of medical liaison executives to promote unlicensed medicines and to promote off-licence indications for other products.
In its ruling the authority said that “the arrangements …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial